Search research articles
Contact Us
Filters
Showing results (501-510 of 523) with videos related to
Page
of 53
Sort By:
International Journal of Environmental Research and Public Health
|
January 28, 2026
Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on COVID-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C: The HERO Study
Snehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Leukemia
|
March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG
J van der Werff Ten Bosch, S Suciu, A Thyss, et al.
British Journal of Cancer
|
September 17, 2014
The AURORA initiative for metastatic breast cancer
D Zardavas, M Maetens, A Irrthum, et al.
Breast Cancer Research and Treatment
|
June 17, 2016
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study
L M Smyth, N M Iyengar, M F Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 15, 2025
Retreatment of Hepatitis C Virus Among People Who Inject Drugs
Aurielle M Thomas, Alain H Litwin, Judith I Tsui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
A D Seidman, M N Fornier, F J Esteva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2008
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17
J N Ingle, D Tu, J L Pater, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 4, 2021
Measurement batch differences and between-batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values
Yue Ma, Derek L Norton, Carol A Van Hulle, et al.
Breast Cancer Research and Treatment
|
March 23, 2001
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation
J A Cauley, L Norton, M E Lippman, et al.
Forensic Science International. Genetics
|
March 20, 2019
Applicability of the SNPforID 52-plex panel for human identification and ancestry evaluation in a Brazilian population sample by next-generation sequencing
Guilherme do Valle-Silva, Flávia Djenane Nunes de Souza, Letícia Marcorin, et al.
Page
of 53
Search research articles
Search
Showing results (501-510 of 523) with videos related to
Sort By:
Page
of 53
International Journal of Environmental Research and Public Health
|
January 28, 2026
Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on COVID-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C: The HERO Study
Snehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Leukemia
|
March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG
J van der Werff Ten Bosch, S Suciu, A Thyss, et al.
British Journal of Cancer
|
September 17, 2014
The AURORA initiative for metastatic breast cancer
D Zardavas, M Maetens, A Irrthum, et al.
Breast Cancer Research and Treatment
|
June 17, 2016
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study
L M Smyth, N M Iyengar, M F Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 15, 2025
Retreatment of Hepatitis C Virus Among People Who Inject Drugs
Aurielle M Thomas, Alain H Litwin, Judith I Tsui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
A D Seidman, M N Fornier, F J Esteva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2008
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17
J N Ingle, D Tu, J L Pater, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 4, 2021
Measurement batch differences and between-batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values
Yue Ma, Derek L Norton, Carol A Van Hulle, et al.
Breast Cancer Research and Treatment
|
March 23, 2001
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation
J A Cauley, L Norton, M E Lippman, et al.
Forensic Science International. Genetics
|
March 20, 2019
Applicability of the SNPforID 52-plex panel for human identification and ancestry evaluation in a Brazilian population sample by next-generation sequencing
Guilherme do Valle-Silva, Flávia Djenane Nunes de Souza, Letícia Marcorin, et al.
Page
of 53